Clin2
NCT06516419Possibly a fitRecruiting

Stem cell cream for melasma study

Melasma

Treatments studied

Part of Skin clinical trials.

This study tests a cream made from stem cell secretions to see if it can help reduce melasma (dark patches on the face). It may be an option for women who haven't improved with other treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
90 people
Ages
30 years to 60 years
Study type
Interventional

Who can take part

  • You are a woman between 30 and 60 years old.
  • You have melasma (dark patches on your face) or healthy skin for comparison.
  • Your skin type is IV or V (you tan easily and rarely burn).
  • You are willing to sign a consent form to participate.
  • You are not pregnant, breastfeeding, or on hormonal birth control in the last 6 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07121439Not yet recruiting
Serum plus laser for dark spots and melasma

This trial tests if adding a special serum to laser treatment can better treat dark spots from acne and melasma in women with medium to dark skin tones. The serum contains ingredients that may help lighten spots and improve skin tone.

Jakarta Pusat, Jakarta Special Capital Region
NCT07137130Not yet recruiting
Testing a new melasma treatment with TGF Beta 3

This trial tests a treatment called Secretome TGF Beta 3 for women with melasma. It aims to see if this treatment can improve dark patches on the skin.

Central Jakarta, D.k.i Jakarta
NCT07732192Not yet recruiting· Phase 4
Oral Tranexamic Acid Plus Triple Cream for Melasma

This study tests whether adding an oral medication (tranexamic acid) to a standard triple cream for melasma works better than the cream alone. It may help if you have medium-to-severe melasma and are generally healthy.

NCT07540702Recruiting
Platelet-Rich Fibrin vs. Tranexamic Acid for Melasma

This trial tests two injectable treatments for melasma (dark patches on the face): platelet-rich fibrin, which uses your own blood cells to promote healing, and tranexamic acid, a medication that may reduce pigmentation. The study will compare which works better for women with mild to moderate melasma.

Cairo, Cairo Governorate
NCT06780644Not yet recruiting
Comparing two creams for melasma treatment

This trial tests two different triple-combination creams for melasma in women with skin types IV or V. Both creams contain a bleaching agent and a retinoid, but one uses a different steroid. The goal is to see which is safer and works better.

Central Jakarta, DKI Jakarta
NCT07495748Not yet recruiting
Metformin or tranexamic acid cream for melasma

This trial tests whether a cream containing metformin or tranexamic acid can reduce melasma (dark patches on the face). It aims to see which treatment works better.

Rawalpindi, Punjab Province

Hear when a new Melasma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.